Multidrug- and Carbapenem-ResistantPseudomonas aeruginosain Children, United States, 1999

Multidrug- and Carbapenem-ResistantPseudomonas aeruginosain Children, United States, 1999–2012

Published:2016-11-16 Issue: Volume: Page:piw064
ISSN:2048-7193
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:JPIDSJ

Author:

Logan Latania K.,Gandra Sumanth,Mandal Siddhartha,Klein Eili Y.,Levinson Jordan,Weinstein Robert A.,Laxminarayan Ramanan,

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Bill and Melinda Gates Foundation

Princeton University

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/jpids/article-pdf/doi/10.1093/jpids/piw064/8233149/piw064.pdf

Reference62 articles.

1. The Accessory Genome of Pseudomonas aeruginosa

2. The type III secretion system of Pseudomonas aeruginosa: infection by injection

3. Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia

4. Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

5. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Atlanta, GA: Center for Disease Control and Prevention; 2013: pp 1–114.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of ceftolozane/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017–2021, China;Journal of Global Antimicrobial Resistance;2024-09

2. Hospital and municipal wastewater as a source of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in the environment: a review;Environmental Science and Pollution Research;2024-07-25

3. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality;Journal of Hospital Infection;2024-07

4. Ceftazidime–Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development;Antibiotics;2024-06-27

5. The Etiologic Organisms, Risk Factors, and Outcomes of Nosocomial Bloodstream Infections in Pediatric Patients;Infectious Diseases in Clinical Practice;2024-06-14